Temple Rock Holdings Inc.

CYNAPSUS THERAPEUTICS TO PRESENT AT BIOFINANCE 2011 CONFERENCE
TORONTO, ONTARIO--(Marketwire - May 31, 2011) - Cynapsus Therapeutics Inc. (TSX VENTURE:CTH), a specialty pharmaceutical company developing an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease, announced today that Anthony Giovinazzo, President and Chief Executive Officer, will present an overview of the Company at the BioFinance 2011 Conference, being held this week in Toronto. Mr. Giovinazzo will be speaking tomorrow (Wednesday, June 1^st) at 3:00 p.m., at the St. Andrew's Club & Conference Centre, 150 King Street West. MORE>>